VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,913 | -32.0% | 1,035,640 | -45.9% | 0.61% | -49.9% |
Q2 2023 | $8,695 | -55.0% | 1,913,657 | -32.0% | 1.21% | -39.8% |
Q1 2023 | $19,316 | +247.0% | 2,812,257 | +122.7% | 2.01% | +327.2% |
Q4 2022 | $5,566 | -99.8% | 1,262,820 | -40.1% | 0.47% | +139.8% |
Q3 2022 | $2,868,000 | -79.3% | 2,109,900 | -27.5% | 0.20% | -79.7% |
Q2 2022 | $13,861,000 | +156.6% | 2,909,430 | +4.5% | 0.97% | +240.5% |
Q1 2022 | $5,402,000 | -33.4% | 2,784,600 | +29.4% | 0.28% | -16.5% |
Q4 2021 | $8,111,000 | +21.4% | 2,151,215 | -31.3% | 0.34% | +13.7% |
Q3 2021 | $6,680,000 | -84.5% | 3,133,100 | -35.0% | 0.30% | -85.1% |
Q2 2021 | $43,027,000 | +146.1% | 4,819,783 | +152.6% | 2.01% | +133.0% |
Q1 2021 | $17,482,000 | +72.4% | 1,907,753 | -49.1% | 0.86% | +78.6% |
Q4 2020 | $10,143,000 | -10.2% | 3,748,083 | -14.4% | 0.48% | -30.7% |
Q3 2020 | $11,297,000 | -68.2% | 4,377,231 | -28.2% | 0.70% | -70.4% |
Q2 2020 | $35,563,000 | +52.1% | 6,098,060 | +24.8% | 2.35% | +95.3% |
Q1 2020 | $23,378,000 | +390.9% | 4,885,625 | -20.5% | 1.20% | +311.6% |
Q4 2019 | $4,762,000 | -22.2% | 6,144,000 | +121.8% | 0.29% | -47.8% |
Q3 2019 | $6,122,000 | -81.3% | 2,769,878 | -43.1% | 0.56% | -81.6% |
Q2 2019 | $32,780,000 | +179.6% | 4,869,870 | +327.8% | 3.04% | +150.3% |
Q1 2019 | $11,725,000 | -40.0% | 1,138,372 | -28.7% | 1.22% | -34.4% |
Q4 2018 | $19,548,000 | +423.9% | 1,597,228 | +12.7% | 1.86% | +619.0% |
Q3 2018 | $3,731,000 | +28.5% | 1,417,637 | +6.0% | 0.26% | +11.2% |
Q2 2018 | $2,904,000 | -65.4% | 1,337,422 | +7.4% | 0.23% | -67.8% |
Q1 2018 | $8,381,000 | +69.6% | 1,244,704 | -35.4% | 0.72% | +255.2% |
Q4 2017 | $4,942,000 | -91.8% | 1,927,221 | -66.5% | 0.20% | -91.0% |
Q3 2017 | $60,062,000 | +57.0% | 5,755,214 | +47.3% | 2.25% | +59.6% |
Q2 2017 | $38,248,000 | +13.1% | 3,907,954 | -28.5% | 1.41% | +0.3% |
Q1 2017 | $33,810,000 | +257.3% | 5,465,047 | -25.5% | 1.41% | +313.8% |
Q4 2016 | $9,462,000 | -78.5% | 7,330,977 | +6.3% | 0.34% | -82.7% |
Q3 2016 | $43,922,000 | -53.8% | 6,895,775 | +12.6% | 1.97% | -59.2% |
Q2 2016 | $95,042,000 | – | 6,125,947 | – | 4.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |